Contact
Please use this form to send email to PR contact of this press release:
Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
TO:
Please use this form to send email to PR contact of this press release:
Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
TO: